Collegium Pharmaceutical, Inc. Balance Sheet
COLL / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
Collegium Pharmaceutical, Inc. had $1.7B in total assets and $302M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $231.3M | $70.6M | $238.9M | $173.7M | $186.4M | $174.1M | $170.0M | $146.6M | $118.7M | $153.2M | $95.7M | $1.6M | $7.6M |
| Accounts Receivable | $211.3M | $228.5M | $179.5M | $183.1M | $105.8M | $83.3M | $73.0M | $77.9M | $10.0M | $2.1M | - | - | - |
| Inventory | $40.9M | $35.6M | $32.3M | $46.5M | $17.4M | $15.6M | $9.6M | $7.8M | $1.8M | $1.3M | - | - | - |
| Current Assets | $691.4M | $482.3M | $537.6M | $420.0M | $315.5M | $277.9M | $255.7M | $237.5M | $133.5M | $158.6M | $96.9M | $4.5M | - |
| PP&E (Net) | $12.0M | $14.3M | $16.0M | $19.5M | $19.5M | $19.0M | $11.9M | $9.3M | $1.8M | $1.0M | $738.0K | $514.0K | - |
| Goodwill | $145.9M | $162.3M | $133.9M | $133.7M | - | - | - | - | - | - | - | - | - |
| Total Assets | $1.7B | $1.7B | $1.1B | $1.2B | $692.1M | $643.8M | $306.3M | $291.2M | $135.6M | $162.0M | $97.7M | $5.1M | - |
| Current Liabilities | $440.0M | $509.5M | $457.9M | $433.7M | $279.6M | $239.5M | $201.8M | $189.1M | $31.5M | $25.6M | $8.4M | $10.4M | - |
| Total Debt | - | - | - | - | - | - | $11.5M | $11.5M | - | $4.1M | - | - | - |
| Shareholders' Equity | $301.7M | $228.8M | $195.4M | $194.8M | $202.9M | $186.0M | $87.4M | $91.6M | $104.1M | $134.9M | $85.1M | -$89.3M | -$68.2M |